Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
10.01
-0.25 (-2.44%)
At close: May 24, 2024, 4:00 PM
10.03
+0.02 (0.20%)
After-hours: May 24, 2024, 7:59 PM EDT

Iovance Biotherapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for IOVA stock have an average target of 25.9, with a low estimate of 19 and a high estimate of 34. The average target predicts an increase of 158.74% from the current stock price of 10.01.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $19 $25.9 $25 $34
Change +89.81% +158.74% +149.75% +239.66%

Analyst Ratings

The average analyst rating for IOVA stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 666666
Buy 666554
Hold 111000
Sell 000000
Strong Sell 000000
Total 131313111110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$32
Strong Buy Reiterates $32 +219.68% May 24, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$32
Strong Buy Reiterates $32 +219.68% May 10, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$18$19
Buy Maintains $18$19 +89.81% Mar 14, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$17$26
Strong Buy Maintains $17$26 +159.74% Mar 7, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$32
Strong Buy Reiterates $32 +219.68% Mar 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
164.41M
from 1.19M
Increased by 13,727.59%
Revenue Next Year
451.06M
from 164.41M
Increased by 174.35%
EPS This Year
-1.37
from -1.89
EPS Next Year
-0.73
from -1.37
Year 2019202020212022202320242025202620272028
Revenue
----1.19M164.41M451.06M728.58M1.16B1.20B
Revenue Growth
-----13,727.59%174.35%61.53%58.80%3.63%
EPS
-1.59-1.88-2.23-2.49-1.89-1.37-0.730.030.782.04
EPS Growth
--------2,450.00%161.44%
No. Analysts -----16151163
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 261.1M 651.4M 1.2B 2.1B 2.4B
Avg 164.4M 451.1M 728.6M 1.2B 1.2B
Low 32.5M 127.9M 302.7M 445.9M 130.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
21,863.0%
296.2%
157.8%
183.7%
108.2%
Avg
13,727.6%
174.4%
61.5%
58.8%
3.6%
Low
2,636.4%
-22.2%
-32.9%
-38.8%
-88.7%

EPS Forecast

EPS 20242025202620272028
High -1.05 -0.01 1.27 1.42 2.10
Avg -1.37 -0.73 0.03 0.78 2.04
Low -1.75 -1.49 -0.93 -0.43 1.96

EPS Growth

EPS Growth 20242025202620272028
High - - -
4,532.4%
169.1%
Avg - - -
2,450.0%
161.4%
Low - - - -
151.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.